Pharmacological Management of Acute Disturbance

The areas covered will include: –

• Patient experience of acute disturbance
• Restrictive practice legal and ethical issues
• De-escalation techniques
• Evidence for the use of oral and RT medication in acute disturbance
  → Benzodiazepines, antipsychotics and antihistamines
  → Other medications
• Pharmacokinetics of the oral and RT medicines
• Adverse effects and the risks associated with the medication used in acute disturbance (including HDAT)
• Use of oral and RT medication in special population
  → Pregnancy
  → Learning Disabilities
  → Children and Adolescents
  → Older age and frailty including dementia
  → Pre-hospital and acute hospital settings
• Use of Acuphase™
• High dose antipsychotics
  → Practical scenarios including switching, next choice, and administering in difficult settings.
• Monitoring of physical health, review of response, and debriefing

Teaching will be led by practicing specialist pharmacists, a patient representative, and a nurse consultant.  It will be delivered via peer-reviewed evidence-based lectures, clinical scenarios, and discussion groups.  Participants are sent details of pre-course preparation associated with the topics, enabling them to prepare and get as much as possible from the sessions themselves.

CMHP or NAPICU Members Rate- £125

Non-Members Rate – £150

How to register for the course?

Please fill in the registration form by Click Here Then please send this to CMHP – info@cmhp.org.uk

Please note: Applications for this event will be acknowledged via confirmatory letter and invoice.  If you do not receive this within 5 working days of your application please contact Wendy directly on info@cmhp.org.uk
For further information about CMHP Education courses, please contact CMHP Education Co-Lead Orla Macdonald: Education@cmhp.org.uk.

For any additional information after you have registered to attend this course please contact NAPICU – info@napicu.org.uk

The views expressed within teaching delivered by any individual during a CMHP or NAPICU event are those of the presenter and not of the organisation itself. Materials are reviewed for accuracy of content but anyone attending any educational event hosted by either organisation must take professional responsibility for their own clinical decisions.

Any discussion on off-license or unlicensed medicine use must not be taken as unreserved support for such prescribing. Attendees must be aware of the contents of all relevant Summaries of Product Characteristics as well as any relevant local or national guidelines when prescribing or giving prescribing advice.